To isolate new types of vesicular stomatitis virus (VSV) mutants, a four-stage screen was developed which identifies and characterizes mutants capable of complementing the defect in the VSV temperature-sensitive mutant tsGll. Two types of mutants of VSV, Indiana serotype, have been found by using the screen; they are new temperature-sensitive mutants which are, of necessity, not in complementation group I and mutants which do not produce plaques under conditions of single infection at 31 C (the normal permissive temperature) and are, therefore, called complementation-dependent mutants. The newly isolated, temperature-sensitive mutants fall into three complementation groups, two of which are congruent with known complementation groups; the newly identified group extends to six the number of complementation groups of VSV Indiana. The nature of the complementation-dependent mutants has not been established, but one was shown to not contain a significant deletion in its nucleic acid.
Temperature-sensitive mutants of vesicular stomatitis virus (VSV), as well as host-range mutants, have been isolated in a number of laboratories (4, 6-9, 11, 13, 16) . Of the fiye complementation groups of mutants in the Indiana serotype, complementation group I contains most of the mutants which have been isolated; it presumably corresponds to the virion-associated transcriptase which is the L (large) protein (2, 5, 12, 18) . Group V appears to represent the envelope-associated G protein (21) . Groups II, III, and IV have less certain associations. Mutants of the New Jersey serotype of VSV fall into six complementation groups (14) .
To increase the catalog of VSV mutants, we initiated a program of isolation of conditional lethal mutants which would not necessarily depend on high temperature as the nonpermissive condition. A way was especially sought which would allow the isolation of possible amber mutants and complementing deletions (as opposed to defective, interfering particles which do not appear to complement; 15). As the procedure developed, it also automatically eliminated group I ts mutants and therefore generated new mutants in the other groups.
The conditional system involved identification of mutants able to grow by complementa- tion with a known ts mutant at high temperature but unable to grow by themselves at high temperature. The mutants were screened by infecting cells at a high multiplicity of infection (MOI) with the ts mutant, co-infecting with mutagenized VSV at a low MOI, and plating the infected cells for infective centers at high temperature on a monolayer of uninfected cells. All mutants isolated this way can be called complementation dependent, but we have reserved the notation cd for mutants which appeared to be complementation-dependent but not temperation sensitive.
The details of the screen and some mutants which have been selected with it are described here. We caution investigators who wish to use the methods that the procedures work well as described, but that even small variations in parameters such as temperature or MOI can lead to problems.
MATERIALS AND METHODS
Cells and media. Mouse L cells were grown in -ontinuous suspension culture at 5 x 10, to 1 x 106 cells/ml in Joklik-modified minimal essential medium (GIBCO) with added 7% fetal bovine serum. Monolayer cultures were prepared by seeding 5 x 106 L cells per 5-cm plastic tissue culture plate 1 to several hours before use. These cultures were maintained in medium supplemented with 1.8 mM CaCl,, and incubations were conducted at the indicated temperatures in a humidified atmosphere of 5% CO,. Purified virus stocks, free of interfering DI-T particles, were prepared on Chinese hamster ovary cells as described previously (17) .
Viruses. The wild-type strain of VSV used in these experiments was the large-plaque variant of the Indiana serotype isolated and described by Wagner et al. (19) . Plaque assays were carried out as previously described (19) , with appropriate medium and serum for L-cell monolayers. All VSV temperature-sensitive (ts) mutants of the G (Glasgow) series and tsO45 (from the Orsay collection) were kindly supplied by C. R. Pringle.
Preparation of mutagenized virus stocks. Purified wild-type stocks of VSV were treated as described with one of the following mutagens.
(i) 5-Fluorouracil. A suspension culture of 5 x 107 L cells in 10 ml of medium with 1.8 mM CaCl, was infected with wild-type VSV at an input MOI of 0.5. After an adsorption period of 30 min at 31 C, the samples were centrifuged to remove unadsorbed virus and suspended in 10 ml of medium plus 4% serum containing 0.3 to 1.0 mg of 5-fluorouracil per ml. The infected cells were incubated in suspension for 8 h at 31 C, after which time the supernatants were collected, dialyzed against the medium, and stored at -70 C. Virus yields were 1.5 x 10-1 to 1.3 x 10-' of those obtained in the absence of mutagen.
(ii) N-methyl-N'-nitro-N-nitrosoguanidine. Purified stock suspensions of VSV were incubated at room temperature for 15 min in 1.0 mg of nitrosoguanidine per ml by the method of Burge and Pfefferkorn (1). After dialysis against fresh medium, the samples were stored at -70 C. Survival of the virus was 2 x 10-4.
(iii) Nitrous acid. By the procedure of Granoff (10) , VSV stocks were incubated at room temperature with 1 M NaNO2 in 0.25 M sodium acetate buffer (pH 4.8 Examination of virus in complementation plaques (stage IV; Fig. 1 ). To examine the content of complementation plaques, the agar over such plaques was collected in a capillary tube, and the virus was released into 1 ml of medium as described (17) . The virus was plated on L-cell monolayers which were incubated for 2 days at 31 C, and well-isolated plaques were then analyzed to determine if they contained tsGll, a new ts mutant, or something else.
For the analysis, plates containing L cells suspended in agar were used (3). For these, a 15-ml agar base layer was prepared in plastic petri dishes (15 by 100 mm); it consisted of 0.9% agar, medium, 1.8 mM CaCl,, nonessential amino acids, and 2% fetal calf serum. Over this base layer was poured a suspension of 107 L cells in the same agar medium which was allowed to solidify. Some plates were also seeded with 4 x 106 L cells freshly infected with tsGll at an MOI of 5 in the top layer in addition to the uninfected cells. The plaques to be tested were stabbed with a sterile toothpick, and the toothpick was then stabbed into identical positions on three plates of L cells in agar suspension, the last plate containing tsGll-infected cells. After a number of plaques had been replicated onto the three plates, one plate was incubated at 31 C, one was incubated at 38.5 C, and the tsGll-containing plate was incubated at 38.5 C. After 2 days, the plates were scored for growth, and the results for any one tested plaque were recorded as (+) or (-) for each of the three plates. These were incorporated into a three-place code where growth at 31 C, 38.5 C, and 38.5 C plus helper were serially represented. A result of (+ --) was indicative of tsGll and a result of (+ -+) indicated a new ts mutant. The (+ + +) result is discussed below.
The new ts mutants were harvested from the 31 C replica plates and cloned twice, and then purified stocks free of defective, interfering particles were prepared (17) . indicate places in the screen where 38.5 C complementation plaques were picked and examined in stage IV of the assay. tsG41 because of the high background yields obtained with these mutants. Controls for each member of a tested pair of mutants were singly infected at twice the MOI used in the mixed infection. Thirty minutes was allowed for adsorption at 39 C (39 C was used for this assay rather than 38.5 C because of the high background yield at the lower temperature). The monolayers were washed twice with 5.0 ml of medium to remove unadsorbed virus and then covered with 5 (4, 9) . Because our strategy for isolation of new mutants involved infection of all members of a population of cells by a helper mutant, infection of some cells by a single particle of a new mutant, and then determination of productive infective centers as an assay for complementation, the feasibility of this methodology was established by using known temperature-sensitive VSV mutants.
Mutant tsGll acted as an efficient helper for complementation in the infective center assay with mutants from groups II, III, IV, and V. Table 1 shows the relative plating efficiency of the tested mutants at 38.5 C (nonpermissive temperature) and 31 C (permissive temperature) along with a coefficient which measures their ability to complement tsGll (calculated as described in the Materials and Methods). Mutant tsGll complements tsG22, tsG33, tsG41, and tsO45 efficiently enough that almost all of the particles able to form plaques at 31 C can be detected by complementation in the infective center assay. The data also confirm that tsGll, tsG13, and tsG114 are all in the same complementation group.
To determine if the complementation plaques arising in the infective center assay contained any recombinant progeny, the plaques were assayed for wild-type virus. More than 99% of the virus in these plaques was still temperature sensitive. A few particles able to form plaques at 38.5 C were detected, but further replating of these plaques did not yield stable recombinants. We conclude that the complementation plaques contain mainly the ts parent viruses plus a few aggregated particles or heteropolyploid particles in which the genomes of both parents are enclosed in a single envelope. Such particles have been previously implicated in genetic studies with VSV ts mutants (20) .
Mutants in group I are especially well-suited as helpers in this complementation test because at high MOI they give little or no background growth in the infective center assay by themselves. Mutants from other groups were less suitable as helpers; tsG22 gave too high a background at 38.5 C; tsG41 gave only minute complementation plaques at 38.5 C, and tsG22 gave a complementation efficiency coefficient of 0.1 to 0.5. We therefore used tsGll as the helper virus in attempts to isolate complementation dependent mutants.
Mutant screen. The procedure used to screen for complementation-dependent mutants is outlined in Fig. 1 . In stage I, L cells were infected at an MOI of 5 with tsGll and at an MOI of 0.01 with mutagenized wild-type VSV. These mixedly infected cells were then plated onto confluent L cell monolayers and incubated at 38.5 C (infective center assay described above). Plaques which formed would be due either to residual wild-type virus in the mutagenized stock or to complementation between a mutant and the tsGll helper.
To distinguish wild-type virus from new mutants, isolated plaques from the infective center assay were eluted into 1 ml of medium. In stage II of the screen (Fig. 1) Stage IV of the assay was designed to distinguish new ts mutants from cd mutants and to allow isolation of the new ts mutants. Individual plaques arising at 38.5 C, from assays marked in Fig. 1 with an asterisk, were picked and plated at 31 C. Isolated plaques from these plates were then picked with sterile toothpicks and transferred to grid positions on three separate plates each containing L-cell suspensions in agar. One of these plates was also seeded with tsGll-infected cells. The tsGll-containing plate along with one of the other two were incubated at 38.5 C; the third plate was incubated at 31 C. The pattern of growth of virus from one tested plaque was scored as (+) or (-) on each of the three plates and recorded as a three-place code.
All plaques submitted to stage IV analysis had an excess of tsGll virus because they arose due to complementation by tsGll. Therefore, the most frequent result at stage IV was (+ --). In some of the plaques, a percentage of the virus gave a (+ -+) result. These were classed as non-group I, ts mutants because they could grow by themselves at 31 C but not at 38.5 C, and they were able to grow at 38.5 C when complemented by tsGll. For such mutants, the plaques on the 31 C stage IV plate were picked, the virus was recloned 2 or 3 times at 31 C, and a stock was prepared. Further analysis of such plaques is given below.
The proportion of new ts mutant virus in an initial 38.5 C plaque was determined from the ratio of plaques at 38.5 C with added tsGll to plaques at 31 C and depended on the point on the screen from which the plaque was obtained. Stage IV results indicating true cd mutants will be described below.
Characterization of new temperature-sensitive mutants. The new series of mutants have been designated as M mutants to denote their origin in Massachusetts, in accordance with the recommendations for a uniform VSV ts mutant nomenclature (4) . After the complementation analysis was completed, the tsM mutants were assigned numbers in a fashion similar to that of Pringle (13) where the first numeral denotes the complementation groups, whereas the last two numerals indicate the number of the mutant within the group. Complementation of the M mutants with representative group I, II, III, IV, and V mutants from the Glasgow and Orsay collections was also carried out (Table 4) . Mutants tsM301 and tsM302 failed to complement only tsG33 and therefore appeared to be in group III. Similarly, tsM501 and tsM502 could not supply a Values in the table are expressed as a complementation index (the ratio of the mixed infection yield to the yield of the more leaky parent), and are the means from duplicate platings in one to three experiments.
b Values in parentheses are the virus yields obtained in single infections at 39 C in PFU/ml. Wild-type VSV gave a yield of 5 x 106 PFU/ml under these conditions.
c Italicized values are greater than 1.5 and represent significant complementation between the two mutants. the missing function to tsO45 and therefore appeared to be group V mutants. Mutant tsM502 did not complement tsG41, but the data clearly place tsM502 in the same group as tsM501 (Table 3) . Mutant tsG41 complements poorly and tsM502 grows poorly even at 31 C so their lack of complementation is understandable.
It was not possible to associate mutants tsM601, tsM602, and tsM5/6-03 with known complementation groups. Mutant tsM602 appears to belong to a separate complementation group from those already characterized; we consider it group VI. The data on tsM601 (Table  4) suggest that it might be in group IV, but its association with tsM602 (Table 3 ) and its slow growth at 31 C make this designation unlikely. Mutant tsM5/6-03 complements tsG41 quite well; in spite of its being a double mutant, it is the best argument that group VI is different from group IV.
Properties of the ed mutants. Two plaques derived from stage I of the screen contained 5 to 20% of virus capable of complementing tsGll at stage III (compared with their titers at 31 C), but no plaques giving a (+ -+) result at stage IV. These two mutants have been called cdMl and cdM2. Table 5 presents their history along with a comparison of their behavior in stage IV assays to that of the new ts mutants. When over 1,000 clones derived from complementation plaques were analyzed, about 1.5% gave a (+ + +) result. Between 16 and 40% of clones derived from the ts mutant complementation plaques gave a (+ -+); none gave the (+ + +) result, but only 107 were analyzed.
Clones scoring as (+ + +) at stage IV for the cd mutants might be thought to be wild-type virus, but recloning of the virus growing without added helper at 38.5 C gave almost entirely ts virus with, again, an occasional (+ + +) result.
Even a third serial analysis revealed no stable wild-type virus. We conclude that 1.5% of the virus in complementation plaques of the cd mutants are heteropolyploids or aggregates which grow at 38.5 C in the absence of helper. Aside from these rare particles, the plaques contain tsGll plus 5 to 20% of a cd virus which Fig. 1 ) at 31 C. b Percentage of total is shown in parenthesis. c Positive results of stage IV assays as described in Fig. 1 . The three (+) or (-) symbols represent, left to right, assays at 31, 38.5, and 38.5 C with added tsGll. All other tested plaques showed a (+ --) pattern indicative of a tsGll plaque. does not grow by itself at 31 C or 38.5 C but will grow in cells which are co-infected by tsGll.
Physical properties of mutant cdMi. To produce a stock of VSV containing as high as possible a percentage of cdMl, a plaque originating from single infection by tsGll and cdMl was chosen. Such plaques are formed by aggregates or heteropolyploids and arise during stage IV assays on plates incubated at 38.5 C without added tsGll. One such plaque was eluted and mixed vigorously to disaggregate clumps, and its contents were analyzed by sedimentation through a sucrose gradient. Portions of the fractionated gradient were analyzed for VSV at 31 C and 38.5 C. A portion was also assayed for its ability to complement tsGll in an infective center assay. Mutant cdMl, detected as complementing virus, cosediments with tsGll, detected at 31 C (Fig. 2) . Mutant cdMl therefore does not contain a large deletion of the VSV genome.
Virus able to grow at 38.5 C without added helper was found in two regions of the sucrose gradient (Fig. 2) . Some cosedimented with the main peak of tsGll; it probably represents simultaneous infections of cells in the plaque assay monolayer by tsGll and cdMl in the peak, because dilutions of the peak fraction showed nonlinearity of plaque number at 38.5 C with dilution. Of more interest is the virus detected at 38.5 C which sedimented ahead of the main peak. In this region of the sucrose gradient, approximately equal numbers of plaques were detected with or without tsGll at 38.5 C, indicating that aggregates or heteropolyploids were present (insert to Fig. 2 ).
DISCUSSION
We have described a new method for selecting VSV conditional lethal mutants for which the permissive condition is complementation by tsGll. In principle, the system could be used with other ts mutants as the helper in complementation, but none of the mutants we tested could be used because they were unsatisfactory in stage I of the screen.
With tsGll, new mutants were isolated after various mutagenesis procedures. Most of these were new ts mutants in complementation groups other than group I. Two mutants showed no detectable new ts virus and were therefore designated cd mutants to denote their obligate complementation dependence.
The new ts mutants were isolated as complementation-dependent mutants and, presumably because of the method of isolation, they all had very little virus able to grow at 38.5 C, and they all complemented well. They fell into three complementation groups when compared among themselves for complementation. One of them appeared to be in two complementation groups and was assumed to be a double mutant.
When the new ts mutants were compared to the existing Glasgow and Orsay mutants, two of the complementation groups of the new mutants were congruent with the standard groups. One of the complementation groups of the new mutants appeared to complement mutants from all of the existing groups; this group was therefore designated group VI, and its mutants were assigned numbers beginning with a 6. The New-Jersey serotype of VSV contains six known complementation groups (14) , but up to now VSV Indiana has had only five. There are only five well-established VSV Indiana proteins, so either a sixth protein exists or two of the complementation groups correspond to one protein.
The two mutants designated cd are clearly (Fig. 1) , was eluted in 1.0 ml of medium. This plaque eluate was layered onto 36 ml of a 5 to 40% sucrose gradient in phosphate-buffered saline and centrifuged at 21,000 rpm for 50 min at 4 C in an SW27 rotor. Sedimentation was from right to left. A hollow rod attached to tubing was inserted to the bottom of the gradient, and a Buchler polystaltic pump was used to collect 1.2-ml fractions which were titered by plaque assay at 31 C and 38.5 C. In addition, 0.1-ml samples of each gradient fraction were assayed for the presence of virus capable of complementing tsGll by an infective center complementation assay. The insert shows fractions 11 to 23 with a more sensitive scale. Symbols: 0, 31 C titer; 0, 38.5 C titer; A, titer of complementing virus. mutants never gave rise to virus other than tsGll which was capable of growth at 31 C but not at 38.5 C (Table 5 ). Rare progeny from complementation plaques are able to grow at 31 C and at 38.5 C in the absence of helper tsGll. These progeny appear to arise from mixed particles containing a tsGll genome and a cd mutant genome; they are not wild-type virus because they never breed true.
The existence of particles with two genomes has previously been observed with VSV (20 (Fig. 2) as particles sedimenting faster than virions which score with approximately equal efficiency at 38.5 C with or without added helper. The nature of the cd mutants has not been established. The one which was studied is not a large deletion mutant because it sediments at the same rate as standard VSV. In principle, cd mutants could be missense, nonsense, frameshift or deletion mutants. To study them in detail at this time would be difficult because the cd stocks contain 80 to 95% of tsGll. Their study will depend on the isolation of cd mutant stocks which contain less tsGll or the development of a conditional state where they can grow by themselves. Suppressor cells growing nonsense mutants would be such a condition.
